Enovis (ENOV) revenue breakdown
By segment, Prevention & Recovery: is the largest at 51% of fiscal 2025 revenue; Reconstructive: grew fastest, 34% a year over 5 years.
By product, Consumables is the largest at 72% of fiscal 2018 revenue, growing 14% a year over 1 years.
Revenue by segment
Fiscal years, as Enovis reports them in its 10-K filings; fiscal 2025 total $2.2B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prevention & Recovery: | — | — | — | — | $863M | $1.0B | $1.0B | $1.1B | $1.1B | $1.1B | 51% |
| Reconstructive: | — | — | — | — | $258M | $400M | $535M | $630M | $1.0B | $1.1B | 49% |
| Fabrication Technology | $1.8B | $1.9B | $2.2B | $2.2B | — | — | — | — | — | — | — |
| Air and Gas | $1.4B | $1.4B | $1.5B | — | — | — | — | — | — | — | — |
| Medical Technology | — | — | — | $1.1B | — | — | — | — | — | — | — |
Revenue by product
Fiscal years, as Enovis reports them in its 10-K filings; fiscal 2018 total $2.2B.
| Products | 2017 | 2018 | Share |
|---|---|---|---|
| Consumables | $1.4B | $1.6B | 72% |
| Equipment | $557M | $624M | 28% |
Revenue by region
Fiscal years, as Enovis reports them in its 10-K filings; fiscal 2025 total $2.2B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $794M | $478M | $541M | $1.5B | $840M | $1.0B | $1.1B | $1.2B | $1.2B | $1.3B | 58% |
| Foreign locations | $2.4B | $1.5B | $1.7B | $1.9B | $281M | $396M | $500M | $555M | $862M | $953M | 42% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ENOV.
Open ENOV in InvestinglyQuestions
Where does Enovis make its money?
In fiscal 2025, by segment: Prevention & Recovery: $1.1B, Reconstructive: $1.1B.
From Enovis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.